Precision medicine (PM) is a rapidly evolving healthcare approach that considers an individual’s unique genetic makeup, environmental factors, and lifestyle choices and is expected to play a significant role in the male sexual dysfunction (MSD) field by enabling tailored treatments, improving diagnostic accuracy, and facilitating a better understanding of the underlying causes of sexual health issues. The following sections discuss the expected effects of PM on MSD.
IMPROVED DIAGNOSTIC ACCURACY
PM allows for identifying specific genetic markers [1], hormonal imbalances [2,3], and other physiological factors that contribute to sexual dysfunction. By analyzing an individual’s genetic and biochemical profiles, healthcare providers can better understand the root cause of sexual dysfunction; consequently, this can be used to design targeted treatment plans that address the unique factors contributing to a patient’s condition, resulting in more accurate diagnoses and improved outcomes.
DEVELOPMENT OF TARGETED THERAPIES
PM can facilitate the development of targeted therapies for MSD by identifying specific molecular targets and associated pathways [4]. For example, researchers may identify new drug targets by analyzing the genetic and molecular factors involved in erectile dysfunction or premature ejaculation [5]. Targeted therapies offer improved efficacy and fewer side effects than those seen with traditional medications, ultimately leading to better patient outcomes.
PERSONALIZED TREATMENT PLANS
PM can help create treatment plans considering an individual’s unique genetic, environmental, and lifestyle factors that are likely to be effective for specific patients [6]. This could involve combining pharmacological interventions with lifestyle modifications, such as dietary changes and stress management techniques, to achieve optimal results [7]. Moreover, personalized treatment plans can help reduce the risk of adverse effects and drug interactions as healthcare providers can consider a patient’s unique genetic profile in prescribing medication.
ENHANCED UNDERSTANDING OF SEXUAL DYSFUNCTION ETIOLOGY
PM can help uncover the complex interplay between the genetic, environmental, and lifestyle factors that contribute to MSD [8]. This enhanced understanding could lead to developing novel treatment strategies and preventive measures to address the root causes of sexual health issues. By identifying specific risk factors, healthcare providers can target interventions for at-risk individuals, ultimately reducing the overall prevalence of sexual dysfunction.
INTEGRATION OF MULTIDISCIPLINARY CARE
Applying PM to MSD highlights the need for a multidisciplinary treatment approach. Genetic counselors, urologists, endocrinologists, sexologists, and mental health professionals should collaborate closely to develop comprehensive treatment plans that address the various factors contributing to sexual dysfunction [9]. The integrated care model can help ensure that patients receive the most effective targeted interventions for their specific needs.
FOCUS ON PREVENTION
As PM helps to identify the genetic, environmental, and lifestyle factors that contribute to MSD, there will be a growing emphasis on preventative measures. By encouraging patients to adopt healthier lifestyles, such as regular exercise, balanced diets, and stress management techniques, healthcare providers can help reduce the incidence of sexual dysfunction. Additionally, genetic testing and counseling can identify individuals who have a higher risk of certain sexual health issues, allowing early intervention and implementation of targeted preventative measures.
ETHICAL CONSIDERATIONS AND DATA PRIVACY
The widespread adoption of PM for MSD raises important ethical considerations, particularly regarding data privacy and informed consent. Healthcare providers and researchers must ensure that patients’ genetic information is protected and that they are aware of the potential implications of genetic testing. Establishing robust ethical frameworks and maintaining transparency are crucial for the successful integration of PM in the field of MSD.
Overall, PM is poised to revolutionize the field of MSD by enabling personalized targeted treatments that address the underlying causes of sexual health issues.
Footnotes
CONFLICTS OF INTEREST: The author has nothing to disclose.
FUNDING: This work was supported by clinical research grant from Pusan National University Hospital (2022).
- Research conception and design: Hyun Jun Park.
- Data acquisition: Hyun Jun Park.
- Statistical analysis: Hyun Jun Park.
- Data analysis and interpretation: Hyun Jun Park.
- Drafting of the manuscript: Hyun Jun Park.
- Critical revision of the manuscript: Hyun Jun Park.
- Obtaining funding: Hyun Jun Park.
- Administrative, technical, or material support: Hyun Jun Park.
- Supervision: Hyun Jun Park.
- Approval of the final manuscript: Hyun Jun Park.
References
- 1.Lippi G, Plebani M, Montagnana M, Cervellin G. Biochemical and genetic markers of erectile dysfunction. Adv Clin Chem. 2012;57:139–162. doi: 10.1016/b978-0-12-394384-2.00005-x. [DOI] [PubMed] [Google Scholar]
- 2.Corona G, Maggi M. The role of testosterone in male sexual function. Rev Endocr Metab Disord. 2022;23:1159–1172. doi: 10.1007/s11154-022-09748-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Coskuner ER, Ozkan B. Premature ejaculation and endocrine disorders: a literature review. World J Mens Health. 2022;40:38–51. doi: 10.5534/wjmh.200184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Holland BC, Shetty Z, Alanee S. The effect of targeted therapy for genitourinary malignancies on sexual function and fertility. Curr Urol Rep. 2017;18:65. doi: 10.1007/s11934-017-0704-9. [DOI] [PubMed] [Google Scholar]
- 5.Yin GN. Pericyte-derived heme-binding protein 1 promotes angiogenesis and improves erectile function in diabetic mice. Investig Clin Urol. 2022;63:464–474. doi: 10.4111/icu.20220038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chung E, Rhee H. Impact of physical exercise program interventions on erectile function and cardiovascular health in males with prostate cancer. World J Mens Health. 2022;40:361–367. doi: 10.5534/wjmh.210032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.El-Osta A, Kerr G, Alaa A, El Asmar ML, Karki M, Webber I, et al. Investigating self-reported efficacy of lifestyle medicine approaches to tackle erectile dysfunction: a cross-sectional eSurvey based study. BMC Urol. 2023;23:15. doi: 10.1186/s12894-023-01180-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Mitsui Y, Kobayashi H, Yamabe F, Nakajima K, Nagao K. ABO blood type and risk of Peyronie’s disease in Japanese males. World J Mens Health. 2022;40:509–516. doi: 10.5534/wjmh.210126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cirillo L, Fusco GM, Di Bello F, Morgera V, Cacace G, Di Mauro E, et al. Sexual dysfunction: time for a multidisciplinary approach? Arch Ital Urol Androl. 2023 Mar 15; doi: 10.4081/aiua.2023.11236. [Epub] [DOI] [PubMed] [Google Scholar]